Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 44

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 44
---
ant’s
directors, officers and controlling persons against specified liabilities, including liabilities under the Securities Act.

<div align='center'>II-1</div>

Item 16. Exhibits

See the Exhibit Index
on the page immediately following the signature page to this registration statement for a list of exhibits filed as part of
this registration statement, which Exhibit Index is incorporated herein by reference.

Item 17. Undertakings

(a)

The undersigned registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 Registration Statement:                                                                                |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the Registration                                       
 Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change     
 in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities 
 offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or      
 high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if,  
 in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set      
 forth in the “Calculation of Registration Fee” table in the effective Registration Statement.                                               |

| (iii) | To include any material information with respect to the plan of distribution not previously disclosed   
 in the Registration Statement or any material change to such information in the Registration Statement; |

provided, however,
that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference in the Registration
Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the Registration Statement.

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post